about
FGFR3-TACC3 fusion in solid tumors: mini reviewRecent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLCEmerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesTranslating cancer genomes and transcriptomes for precision oncologyNext-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?The PI3K/AKT Pathway and Renal Cell CarcinomaTen things you should know about protein kinases: IUPHAR Review 14Targeting cancer with kinase inhibitorsAdvances in the Molecular Analysis of Soft Tissue Tumors and Clinical ImplicationsPreclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR DysregulationQuaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutationsNTRK gene fusions as novel targets of cancer therapy across multiple tumour typesA survey of best practices for RNA-seq data analysisInhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationTRKing down an old oncogene in a new era of targeted therapyAn Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21)Implementing Genome-Driven Oncology.Recurrent fusion RNA DUS4L-BCAP29 in non-cancer human tissues and cells.Recurrent chimeric fusion RNAs in non-cancer tissues and cells.SpeedSeq: ultra-fast personal genome analysis and interpretation.Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.Discovering and understanding oncogenic gene fusions through data intensive computational approachesChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data miningAcfs: accurate circRNA identification and quantification from RNA-Seq data.Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.Molecular Testing of Lung CancersDetection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal CancerWhat hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.Activating MET kinase rearrangements in melanoma and Spitz tumours.Lack of ROS1 Gene Rearrangement in Glioblastoma MultiformeDetection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population.
P2860
Q26740578-3FA97C86-3797-49A2-9430-4C1B885430EAQ26747276-A9B4DC2D-EAEF-42FB-B200-20AEA45F82B8Q26766271-4F850974-6B9A-4BEE-BC0A-8070A030A77BQ26768158-9868CF24-1CDF-4478-B752-BF1791DD3863Q26777081-5FBB8DB3-7E16-4E39-8E2F-C934127A9329Q26781271-186F0A94-05E5-4AB8-BF66-FBE4C7813DD1Q26800216-0B31C18D-19E6-4971-9718-9C1F50CCA642Q26849417-6284FC75-BFC4-492F-AA40-91FCC721DB20Q26865765-0BD58717-E7C6-425B-AAE1-0AF8303E52D5Q27021848-954ABD51-BD06-4ABB-B442-088479A20E18Q27322795-410893B4-29DE-45D7-88BE-B187B5FD2434Q27328830-95809FA6-556A-4DB3-BF6C-EDEB43FA26CDQ27853138-9D482E8D-A3FA-4B50-B496-C56B356E9D39Q28066821-A252BF51-2D39-4E12-9063-9597276A8174Q28071394-DFF913A4-8077-49D4-A4B5-CFCADDFA5FC4Q28079309-955B5BC9-C1CC-4019-991C-D736BF2E443FQ28254287-305B81C5-FCAC-4E57-866D-A7FA9B5F2A57Q28265615-2B137EB7-F717-4DD2-B091-308BACE00C9DQ28600956-72766B34-706A-4870-B635-49D382B81706Q30235979-DB4E5E24-D435-48CF-9E8C-8D440B1FA605Q30252613-E657B563-00C4-4402-A8BF-197FF6B82AB7Q30277623-950E3186-DCB4-4798-9031-97D38C3B3E64Q30278875-4D74D85C-244B-4AE1-B3B9-F61586E49B7AQ30762699-DB2C426E-C095-4C9D-9ABE-ACCCE65D8B63Q31028108-D45820FD-694C-462C-921A-A5622D5A8BF4Q31083417-65188178-B56A-4418-A97E-BD44B16D1634Q31145443-B55F371E-F591-4BED-BA26-62CF40E734AFQ31147507-5E7EC4E9-5981-4DC7-94D0-F87848C6FC74Q33276475-7A409027-49F8-4381-9963-C8E2590E8548Q33729715-86B59C8E-64A7-42AB-9942-27175A3A8C00Q33898865-48F32708-2342-489B-B87B-ABF2768BDC62Q33899971-295F4452-F7D1-4148-BDE4-2CF8D1898402Q34501536-11D74E10-A0EF-4DF9-9016-ED813943568DQ34514469-71579DB4-8CE5-4474-AD31-395E77EE8635Q34556842-03C5DE00-7C07-4E2F-A0E0-20FA166E9D68Q35212656-75371EE5-E694-487A-9569-B7825DA2257AQ35658282-35BEF426-3FCA-4F93-94AF-97861015EBE9Q35772397-D8F669A9-E002-4DA6-8FC9-FB0889B39C50Q35862636-963648FE-D8D4-4FBF-9580-36EEBB1B33ADQ35871758-E7B81779-C476-43A4-8E9E-D06EA2C6493F
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The landscape of kinase fusions in cancer
@ast
The landscape of kinase fusions in cancer
@en
The landscape of kinase fusions in cancer
@nl
type
label
The landscape of kinase fusions in cancer
@ast
The landscape of kinase fusions in cancer
@en
The landscape of kinase fusions in cancer
@nl
prefLabel
The landscape of kinase fusions in cancer
@ast
The landscape of kinase fusions in cancer
@en
The landscape of kinase fusions in cancer
@nl
P2093
P2860
P356
P1476
The landscape of kinase fusions in cancer
@en
P2093
Christoph Lengauer
Ethan Cerami
Joseph L Kim
Nicolas Stransky
Stefanie Schalm
P2860
P2888
P356
10.1038/NCOMMS5846
P407
P577
2014-09-10T00:00:00Z
P5875
P6179
1002755355